Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
Clicks: 24
ID: 277214
2023
| Reference Key |
liu2023podcastadvances
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Liu, G. |
| Journal | Advances in therapy |
| Year | 2023 |
| DOI | 10.1007/s12325-023-02606-x |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.